We found that TIPE3 expression was significantly downregulated in six cancer types, including BLCA (bladder cancer), CESC (cervical cancer), COADREAD (colon and rectal cancer), HNSC (head and neck cancer), LUNG (lung cancer),and PRAD (prostate cancer) (Fig. 3f). This evidence concerns the gene TIPE3 and cancer.